11β-Hydroxysteroid dehydrogenase 1 activity and gene expression in human adipose stromal cells: Effect on aromatase activity

Journal of Steroid Biochemistry and Molecular Biology

Volumn 60, Issue 3-4, 1997, Pages 247-253

  Yang, K ^a   Khalil, M W ^a   Strutt, B J ^a   Killinger, D W ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; AROMATASE; CARBENOXOLONE; CORTISONE; GLUCOCORTICOID; HYDROCORTISONE;

ADIPOSE TISSUE; ADULT; ARTICLE; BREAST; DRUG EFFECT; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MODULATION; NORTHERN BLOTTING; STROMA CELL;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; ADIPOSE TISSUE; ADOLESCENT; ADULT; ANDROSTENEDIONE; AROMATASE; BREAST; CARBENOXOLONE; CELLS, CULTURED; CORTISONE; DRUG INTERACTIONS; ESTRONE; FEMALE; GENE EXPRESSION; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; HYDROXYSTEROID DEHYDROGENASES; ISOENZYMES; MAMMAPLASTY; MIDDLE AGED; STROMAL CELLS;

EID: 0030964319     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(96)00187-2     Document Type: Article

References (60)

1. Ballard P. L., Delivery and transport of glucocorticoids to target cells. In Glucocorticoid Hormone Action, Monographs in Endocrinology, Ed. Rousseau Baxter. Springer-Verlag, Berlin. 1979, p. 25.
2. Hammond G. L., Smith C. L., Paterson N. A. M. and Sibbald W. J.: A role for corticosteroid-binding globulin in delivery of cortisol to activated neutrophils. J. Clin. Endocr. Metab. 71 (1990) 34-39.
3. Svec F.: The relationships between glucocorticoid biopotency and receptor binding in the AtT-20 cells. Endocrinology 114 (1984) 1250-1258.
4. Chrousos G. P., Etera-Wadleigh S. D. and Karl M.: Syndromes of glucocorticoid resistance. Ann. Intern. Med. 119 (1993) 1113-1124.
5. Murphy B. E. P.: Ontogeny of cortisol-cortisone interconversion in human tissues: a role for cortisone in human fetal development. J. Steroid Biochem. 14 (1981) 811-817.
6. Monder C. and White P. C.: 11β-Hydroxysteroid dehydrogenase. Vitam. Horm. 47 (1993) 187-271.
7. Agarwal A. K., Monder C., Eckstein B. and White P. C.: Cloning and expression of rat cDNA encoding corticosteroid 11β-dehydrogenase. J. Biol. Chem. 264 (1989) 18939-18943.
8. Tannin G. M., Agarwal A. K., Monder C., New M. I. and White P. C.: The human gene for 11β-hydroxysteroid dehydrogenase. J. Biol. Chem. 266 (1991) 16653-16658.
9. Yang K., Smith C. L., Dales D., Hammond G. L. and Challis J. R.: Cloning of an ovine 11β-hydroxysteroid dehydrogenase complementary deoxyribonucleic acid: tissue and temporal distribution of its messenger ribonucleic acid during fetal and neonatal development. Endocrinology 131 (1992) 2120-2126.
10. Moore C. C. D., Mellon S. H., Murai J., Siiteri P. K. and Miller W. K.: Structure and function of the hepatic form of 11β-hydroxysteroid dehydrogenase in squirrel monkey, an animal model of glucocorticoid resistance. Endocrinology 133 (1993) 368-375.
11. Rajan V., Chapman K. E. and Lyons V.: Cloning, sequencing and tissue-distribution of mouse 11β-hydroxysteroid dehydrogenase-1 cDNA. J. Steroid Biochem. Molec. Biol. 52 (1995) 141-147.
12. Edwards C. R. and Stewart P. M.: The cortisol-cortisone shuttle and the apparent specificity of glucocorticoid and mineralocorticoid receptors. J. Steroid Biochem. Molec. Biol. 39 (1991) 859-865.
13. Seckl J. R., Kelly P. A. and Sharkey J.: Glycyrrhetinic acid, an inhibitor of 11β-hydroxysteroid dehydrogenase, alters local cerebral glucose utilization in vivo. J. Steroid Biochem. Molec. Biol. 39 (1991) 777-779.
14. Walker B. R., Yau J. L. and Brett L. P.: 11β-Hydroxysteroid dehydrogenase in vascular smooth muscle and heart: implications for cardiovascular responses to glucocorticoids. Endocrinology 129 (1991) 3305-3312.
15. Monder C., Miroff Y., Marandici A. and Hardy M. P.: 11β-Hydroxysteroid dehydrogenase alleviates glucocorticoid-mediated inhibition of steroidogenesis in rat Leydig cells. Endocrinology 134 (1994) 1199-1204.
16. Naray Fejes Toth A., Watlington C. O. and Fejes Toth G.: 11 beta-hydroxysteroid dehydrogenase activity in the renal target cells of aldosterone. Endocrinology 129 (1991) 17-21.
17. Rusvai E. and Naray Fejes Toth A.: A new isoform of 11 beta-hydroxysteroid dehydrogenase in aldosterone target cells. J. Biol. Chem. 268 (1993) 10717-10720.
18. Yang K. and Yu M.: Evidence for distinct isoforms of 11β-hydroxysteroid dehydrogenase in the ovine liver and kidney. J. Steroid Biochem. Molec. Biol. 49 (1994) 245-250.
19. Agarwal A. K., Mune T., Monder C. and White P. C.: NAD-dependent isoform of 11β-hydroxysteroid dehydrogenase. J. Biol. Chem. 269 (1994) 25959-25962.
20. Albiston A. L., Obeyesekere V., Smith R. and Krozowski Z. S.: Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme. Molec. Cell Endocr. 105 (1994) R11-R17.
21. Steward P. M., Murry B. A. and Mason J. I.: 11β-Hydroxysteroid dehydrogenase in human fetal tissues. J. Clin. Endocr. Metab. 78 (1994) 1529-1532.
22. Naray-Fejes-Toth A. and Fejes-Toth G.: Expression and cloning of the aldosterone target cell-specific 11β-hydroxysteroid dehydrogenase from rabbit collecting duct cells. Endocrinology 136 (1995) 2579-2586.
23. Whorwood C. B., Mason J. I., Ricketts M. L., Howie A. J. and Steward P. M.: Detection of human 11β-hydroxysteroid dehydrogenase isoforms using reverse-transcriptase-polymerase chain reaction and localization of the type 2 isoform to renal collecting ducts. Molec. Cell Endocr. 110 (1995) R7-R12.
24. Edwards C. R., Stewart P. M. and Burt D.: Localisition of 11β-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet 2 (1988) 986-989.
25. Funder J. W., Pearce P. T., Smith R. and Smith A. L.: Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 242 (1988) 583-585.
26. Ulick S., Levine L. S. and Gunczler P.: A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. J. Clin. Endocr. Metab. 49 (1979) 757-764.
27. Stewart P. M., Wallace A. M., Valentino R., Burt D., Shackleton C. H. and Edwards C. R.: Mineralocorticoid activity of liquorice: 11β-hydroxysteroid dehydrogenase deficiency comes of age. Lancet 2 (1987) 281-284.
28. Stewart P. M., Corrie J. E., Shackleton C. H. and Edwards C. R.: Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle. J. Clin. Invest. 82 (1988) 340-349.
29. Mune T., Rogerson F. M., Nikkilä H., Agarwal A. K. and White P. C.: Human hypertension caused by mutations in the kidney isozyme of 11β-hydroxysteroid dehydrogenase Nature Genet. 10 (1995) 394-399.
30. Wilson R. C., Krozowski Z. S. and Li K.: A mutation in the HSD11B2 gene in a family with apparent mineralocorticoid excess. J. Clin. Endocr. Metab. 80 (1995) 2263-2266.
31. Khalil M. W., Strutt B., Vachon D. and Killinger D. W.: Metabolism of dehydroepiandrosterone by cultured human adipose stromal cells: identification of 7α-hydroxydehydroepiandrosterone as a major metabolite using high performance liquid chromatography and mass spectrometry. J. Steroid Biochem. Molec. Biol. 46 (1993) 585-594.
32. Killinger D. W., Strutt B. J., Roncari D. A. and Khalil M. W.: Estrone formation from dehydroepiandrosterone in cultured human breast adipose stromal cells. J. Steroid Biochem. Molec. Biol. 52 (1995) 195-201.
33. MacDonald P. C., Rombaut P. and Siiteri P. K.: Plasma precursors of estrogen. 1. Extent of conversion of plasma 4-androstenedione to estrone in normal males and non-pregnant, normal, castrated and andrenalectomized females. J. Clin. Endocr. Metab. 27 (1967) 1103-1111.
34. Hemsel D. L., Grodin J. M., Brenner P. K., Siiteri P. K. and MacDonald P. C.: Plasma precursors of estrogen. II. Correlation of the extent of conversion of plasma androstenedione to estrone with age. J. Clin. Endocr. Metab. 38 (1974) 476.
35. Haning R. V., Carlson I. H., Flood C. A., Hackett R. J. and Longcope C.: Metabolism of dehydroepiandrosterone sulfate (DS) in normal women and women with high DS concentrations. J. Clin. Endocr. Metab. 73 (1991) 1210-1215.
36. Grodin J. M., Siiteri P. K. and MacDonald P. C.: Source of estrogen production in postmenopausal women. J. Clin. Endocr. Metab. 36 (1973) 207-214.
37. Mahendroo M. S., Means G. D., Mendelson C. R. and Simpson E. R.: Tissue-specific expression in human P450 aromatase. The promoter responsible for expression in adipose tissue is different from that utilized in placenta. J. Biol. Chem. 255 (1991) 11276-11281.
38. Simpson E. R., Mahendroo M. S. and Means G. D.: Aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesis. Endocr. Rev. 15 (1994) 342-355.
39. Simpson E. R., Ackerman G. E., Smith M. E. and Mendelson C. R.: Estrogen formation in stromal cells of adipose tissue of women: induction by glucocorticoids. Proc. Natl. Acad. Sci. U.S.A. 78 (1981) 5690-5694.
40. Perel E., Daniilescu D., Kindler S., Kharlip L. and Killinger D. W.: The formation of 5α-reduced androgens in stromal cells from human breast adipose tissue. J. Clin. Endocr. Metab. 62 (1986) 314-318.
41. Zhao Y., Nichols J. E., Bulun S. E., Mendelson C. R. and Simpson E. R.: Aromatase P-450 gene expression in human adipose tissue. Role of Jak/Stat pathway in regulation of the adipose-specific promoter. J. Biol. Chem. 270 (1995) 16449-16457.
42. Edman C. D. and McDonald P. C.: Effect of obesity on conversion of plasma androstenedionc to estrone in ovulatory and anovulatory young women. Am. J. Obstet. Gynecol. 130 (1978) 456-463.
43. MacDonald P. C., Edman C. D., Hemsell D. L., Porter Y. C. Siiteri P. K.: Effect of obesity on conversion of plasma and androstenedione to estrone in postmenopausal women with and without endometrial cancer. Am. J. Obstet. Gynecol. 130 (1978) 448-455.
44. Killinger D. W., Perel E., Daniilescu D., Kharlip L. and Lindsay W. R. N.: The relationship between aromatase activity and body fat distribution. Steroids 50 (1987) 61-72.
45. Killinger D. W., Perel E., Daniilescu D., Kharlip L. and Lindsay W. R. N.: The influence of adipose tissue distribution on the biological activity of androgens. Ann. NY Acad. Sci. 595 (1990) 199-211.
46. Murphy B. E. P., Wong K. C., Ber R. and Marvin M.: Uptake and metabolism of cortisol by adipose tissue. Clin. Res. 17 (1969) 661-664.
47. Wiedenfeld J., Siegel R. A., Levy J. and Chowers I.: In vitro metabolism of cortisol by human abdominal adipose tissue. J. Steroid Biochem. 17 (1992) 357-360.
48. Yang K., Berdusco E. T. M. and Challis J. R. G.: Opposite effects of glucocorticoid on hepatic 11beta-hydroxysteroid dehydrogenase mRNA and activity in fetal and adult sheep. J. Endocr. 143 (1994) 121-126.
49. Perel E. and Killinger D. W.: The interconversion and aromatization of androgens by human adipose tissue. J. Steroid Biochem. 10 (1979) 623-628.
50. Simpson E. R., Merrill J. C., Hollub A. J., Graham-Lorences S. and Mendelson C. R.: Regulation of estrogen biosynthesis by human adipose cells. Endocr. Rev. 10 (1989) 136-148.
51. Mendelson C. R., Corbin C. J., Smith M. E., Smith J. and Simpson E. R.: Growth factors suppress and phorbol esters potentiate the action of dibutyrylcyclic AMP to stimulate aromatase activity of human adipose stromal cells. Endocrinology 118 (1986) 968.
52. Evans C. T., Merrill J. C., Corbin C. J., Saunders C., Simpson E. R. and Mendelson C. R.: Regulation of estrogen biosynthesis in human adipose stromal cells. J. Biol. Chem. 262 (1987) 6914-6920.
53. Perel E., Daniilescu D., Kharlip L., Blackstein M. and Killinger D. W.: Steroid modulation of aromatase activity in human cultured breast carcinoma cells. J. Steroid Biochem. 29 (1988) 393-399.
54. Hammami M. M. and Siiteri P. K.: Regulation of 11β-hydroxysteroid dehydrogenase activity in human skin fibroblasts: enzymatic modulation of glucocorticoid action. J. Clin. Endocr. Metab. 73 (1991) 326-334.
55. Monder C., Steward P. M., Lakshmi V., Valentino R., Burt D. Edwards C. R. W.: Licorice inhibits corticosteroid 11β-dehydrogenase of rat kidney and liver: in vivo and in vitro studies. Endocrinology 125 (1989) 1046-1053.
56. Whorwood C. B., Sheppard M. C. and Stewart P. M.: Licorice inhibits 11β-hydroxysteroid dehydrogenase messenger ribonucleic acid levels and potentiates glucocorticoid hormone action. Endocrinology 132 (1993) 2287-2292.
57. Whorwood C. B., Franklyn J. A., Sheppard M. C. and Stewart P. M.: Tissue localization of 11β-hydroxysteroid dehydrogenase and its relationship to the glucocorticoid receptor. J. Steroid Biochem. Molec. Biol. 41 (1992) 21-28.
58. Quirk S. J., Slattery J. A. and Funder J. W.: Epithelial and adipose cells isolated from mammary glands of pregnant and lactating rats differ in 11β-hydroxysteroid dehydrogenase activity. J. Steroid Biochem. Molec. Biol. 37 (4) (1990) 529-534.
59. Teelucksingh S., Mackie A. D. R., Burt D., McIntyre M. A., Brett L. and Edwards C. R. W.: Potentiation of hydrocortisone activity in skin by glycyrrhetinic acid. Lancet 335 (1990) 1060-1063.
60. Hemsel D. L., Grodin J. M., Brenner P. F., Siiteri P. K. and MacDonald P. C.: Plasma precursors of estrogen. II. Correlation of the extent of conversion of plasma androstenedione to estrone with age. J. Clin. Endocr. Metab. 38 (1974) 476-480.